Carsten Saft

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

Jan Kassubek, Freimut D. Juengling, Tatjana Awerina Kioschies et al. · PubMed · 2004 · 249 citations

Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects

Christian Beste, Rita Willemssen, Carsten Saft et al. · Neuropsychologia · 2009 · 184 citations

Neurobiological Mechanism, Neuroanatomy, Medicine +10

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

Carsten Saft, Jochen Zange, Jürgen Andrich et al. · Movement Disorders · 2005 · 180 citations

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

Justo García de Yébenes, G. Bernhard Landwehrmeyer, Ferdinando Squitieri et al. · The Lancet Neurology · 2011 · 171 citations

Degenerative Disease, Neuropharmacology, Placebo-controlled Trial +8

An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease

Sigurd D. Süßmuth, Salman Haider, G. Bernhard Landwehrmeyer et al. · British Journal of Clinical Pharmacology · 2014 · 161 citations · Full text